The Hepatitis B vaccine, once a significant public health success, is currently experiencing a decline in prevalence since 1991. Prior to this period, a committee recommended universal vaccination for all newborns, resulting in a substantial decrease in cases of the disease. Data indicates a notable decrease in reported infections within the past few decades. While the vaccine remains effective, the observed reduction in incidence is prompting reassessment of vaccination strategies and potential adjustments to public health programs. The exact reasons for this shift are currently being analyzed by public health officials.
Credits: NYT > Top Stories